DexCom Inc. closed 46.96% short of its 52-week high of $142.00, which the company achieved on March 26th.

DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up ...

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...

The stock's fall snapped a two-day winning streak.

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV – Research Report) ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

DexCom, Inc.'s (NASDAQ:DXCM) stock price has dropped 12% in the previous week, but insiders who sold US$16m in stock over the past year have had less luck. The average selling price of US$117 is ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

With its latest earnings report coming out on Feb. 13, is it a good idea to buy the healthcare stock before then? DexCom's slowing growth a potentially big concern for investors There's been a ...

Hence, I have issued a sell rating on the stock. DXCM came up with its 4Q24 results earlier last month. The results were quite muted but were an improvement over even worse results in 3Q24.